C12N 2502/1178
Spleen cells
C12N2502/1178 (Spleen cells) appears on 2 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 8
- Assignees
- 9
- Inventors
- 28
- Latest grant
- 7 Sep 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 2 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Cell therapy for alzheimer's disease11 Jun 2026US 2026/0158142 A1Board of Regents of the University of Nebraska
- Methods for selectively reducing immunogenicity in a transplant13 Mar 2025US 2025/0084370 A1Transimmune AG
- Anti-cd73 antibody and use thereof25 May 2023US 2023/0159655 A1Akeso Biopharma, Inc.
- Use of veto cells for the treatment of sickle cell disease25 Aug 2022US 2022/0265726 A1Board of Regents, The University of Texas System
- Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity23 Dec 2021US 2021/0393681 A1Therapeutic Solutions International, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.